General
Preferred name
CADRALAZINE
Synonyms
ISF 2469 ()
ISF-2469 ()
ISF2469 ()
Cadral ()
Cadralazina ()
P&D ID
PD014672
CAS
64241-34-5
Tags
available
drug
First approval
1988
Drug Status
approved
investigational
experimental
Max Phase
2.0
Drug indication
Hypertension
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cadralazine (ISF 2469) is an orally active antihypertensive agent. Cadralazine is a peripheral arteriolar vasodilator[1].
PRICE 70
DESCRIPTION Cadralazine (ISF 2469) is a peripheral arteriolar vasodilator and can be used in studies about acting as an antihypertensive drug. (TargetMol Bioactive Compound Library)
Compound Sets
9
ChEMBL Drugs
CHEMBL2106561
DrugBank
DB13452
DrugCentral
461
DrugCentral Approved Drugs
461
DrugMatrix
MedChem Express Bioactive Compound Library
HY-106538
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
T26939
External IDs
21
Properties
(calculated by RDKit )
Molecular Weight
283.16
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
3
Rotatable Bonds
7
Ring Count
1
Aromatic Ring Count
1
cLogP
0.76
TPSA
99.61
Fraction CSP3
0.58
Chiral centers
1.0
Largest ring
6.0
QED
0.64
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Drug Derivative
Source data